Home
About Us
Mission
History
Directory Board
Scientific Advisory Board
Management Team
Science
Our Approach
Pipeline
Oncology
Other Therapeutic Areas
Cancer Stem Cells
Publications & Abstracts
Patients
Overview
Patient Organizations
Professional Organizations
Collaborations
Investors
News
News
Events
Contact Us
Contact
Careers
Pipeline
Genoscience Pharma has developed a growing list of innovative small molecules, a proof of the company’s passion and dedication to patients with serious unmet medical needs
Genoscience Pharma Development Pipeline
Science
Our Approach
Pipeline
Oncology
Other Therapeutic Areas
Cancer Stem Cells
Publications & Abstracts
News
Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer at the Jules Bordet Institute, Brussels
05 April 2018
Clinical significance of high expression of a specific solute carrier transporter in HCC.
11 January 2018
Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer
6 December 2017
Events
The EASL-International Liver Congress Meeting 2018 – Paris, FRANCE
11-15 April 2018
Home
About Us
Mission
History
Directory Board
Scientific Advisory Board
Management Team
Science
Our Approach
Pipeline
Oncology
Other Therapeutic Areas
Cancer Stem Cells
Publications & Abstracts
Patients
Overview
Patient Organizations
Professional Organizations
Collaborations
Investors
News
News
Events
Contact Us
Contact
Careers
